MariMed Inc. (MRMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0975
-0.0067 (-6.45%)
Mar 21, 2025, 3:57 PM EST
MariMed Revenue
In the year 2024, MariMed had annual revenue of $157.96M with 6.30% growth. MariMed had revenue of $39.00M in the quarter ending December 31, 2024, with 0.26% growth.
Revenue
157.96M
Revenue Growth
+6.30%
P/S Ratio
0.25
Revenue / Employee
204.09K
Employees
721
Market Cap
39.83M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 16.04M |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
BioStem Technologies | 210.49M |
MariMed News
- 14 days ago - This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More - Benzinga
- 15 days ago - MariMed Inc. (MRMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - MariMed Inc Reports Q4 2024 Earnings: EPS of -$0.02 Misses Estimate, Revenue of $39. ... - GuruFocus
- 16 days ago - MariMed GAAP EPS of -$0.02, revenue of $39M misses by $3M - Seeking Alpha
- 16 days ago - MariMed Reports Fourth Quarter and Full Year 2024 Earnings - GlobeNewsWire
- 17 days ago - MariMed Q4 2024 Earnings Preview - Seeking Alpha
- 18 days ago - MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware - GlobeNewsWire
- 4 weeks ago - Cannabis Stock Movers For February 17, 2025 - Benzinga